Inconsistent CFC Use Is Unnecessarily Burdening Labs
Inconsistent use of CFCs—especially around replacement claims—is causing costly inefficiencies in healthcare billing.
Inconsistent use of CFCs—especially around replacement claims—is causing costly inefficiencies in healthcare billing.
Despite powerful advances in precision medicine, most doctors remain untrained in these emerging diagnostic tools.
PathAI has received FDA 510(k) clearance for its AISight Dx digital pathology platform, enabling its use in primary diagnosis.
Bio-Rad Laboratories will showcase its latest clinical diagnostic solutions and host a QC workflow optimization workshop at ADLM 2025.
Researchers have developed a handheld TB test that accurately detects tuberculosis in HIV-positive individuals using a single drop of blood.